Drug
Low Dose Corticosteroids
Total Trials
2
Max Phase
-
Type
DRUG
Molecule
-
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
0 source entries across 0 studies. This list may not include all unresolved or historical entries.
Success Metrics
Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(50%)
Phase Distribution
Phase 3
1
50%
Phase 4
1
50%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution2 total trials
Phase 3Large-scale testing
1(50.0%)
Phase 4Post-market surveillance
1(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
2
all time
Status Distribution
Active(1)
Terminated(1)
Detailed Status
Terminated1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
2
Active
0
Success Rate
0.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (50.0%)
Phase 41 (50.0%)
Trials by Status
terminated150%
not_yet_recruiting150%
Recent Activity
Clinical Trials (2)
Showing 2 of 2 trials
NCT07152613Phase 3
Corticosteroids for PJP in Non-HIV Immunocompromised Adults
NCT01742338Phase 4
Dose of Corticosteroids in COPD
All 2 trials loaded
Drug Details
- Intervention Type
- Drug
- Total Trials
- 2